Candel Therapeutics, Inc. Rings the Closing Bell in Celebration of its IPO

ABOUT THIS EVENT

Candel Therapeutics, Inc. (Nasdaq: CADL) visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Paul Peter Tak, M.D., Ph.D., FMedSci, President & CEO, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore